No drug-drug interaction between nelfinavir or indinavir and mefloquine in HIV-1-infected patients

被引：17
|
作者：
Schippers, EF
Hugen, PWH
den Hartigh, J
Burger, DM
Hoetelmans, RMW
Visser, LG
Kroon, FP
机构：
[1] Leiden Univ, Med Ctr, Dept Infect Dis, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Pharm & Toxicol, NL-2300 RC Leiden, Netherlands
[3] Univ Nijmegen, Med Ctr, Dept Clin Pharm, Nijmegen, Netherlands
[4] Slotervaart Hosp, Dept Pharm & Pharmacol, Amsterdam, Netherlands
来源：
AIDS | 2000年 / 14卷 / 17期
关键词：
D O I：
10.1097/00002030-200012010-00023
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：2794 / 2795
页数：2
相关论文
共 50 条
  • [31] NEUROPSYCHOLOGICAL PERFORMANCE IN HIV-1-INFECTED DRUG-ABUSERS
    GRASSI, MP
    PERIN, C
    CLERICI, F
    ZOCCHETTI, C
    CARGNEL, A
    MANGONI, A
    ACTA NEUROLOGICA SCANDINAVICA, 1993, 88 (02): : 119 - 122
  • [32] Comparing the Frequencies of Contraindicated Drug-Drug Interactions Between Differing Antiretroviral Regimens in HIV-Infected Patients
    Jakeman, Bernadette
    Nasiri, Mona
    Ruth, Lindsey
    Morse, Caroline
    Mahatme, Sheran
    Patel, Nimish
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (05) : 365 - 372
  • [33] Therapeutic Drug Monitoring of Indinavir in HIV-Infected Patients Undergoing HAART
    P. Langmann
    M. Zilly
    B. Weißbrich
    S. Desch
    T. Väth
    H. Klinker
    Infection, 2002, 30 : 13 - 16
  • [34] A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir
    Hammer, SM
    Bassett, R
    Squires, KE
    Fischl, MA
    Demeter, LM
    Currier, JS
    Mellors, JW
    Morse, GD
    Eron, JJ
    Santana, JL
    DeGruttola, V
    ANTIVIRAL THERAPY, 2003, 8 (06) : 507 - 518
  • [35] Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir
    Michael W. Jann
    Vicky Spratlin
    Kathryn Momary
    Hailing Zhang
    David Turner
    Scott R. Penzak
    Alan Wright
    Chad VanDenBerg
    European Journal of Clinical Pharmacology, 2012, 68 : 715 - 721
  • [36] Recurrent coronary disease in HIV-infected patients: role of drug-drug interactions
    Bravo, Iria
    Alvarez, Hortensia
    Marino, Ana
    Clotet, Bonaventura
    Molto, Jose
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (07) : 1617 - 1619
  • [37] A Drug-drug Interaction Between Cyclosporine and Nystatin
    Liu, Wei
    Guan, Xin
    Yu, Zhiheng
    Chen, Ken
    Benet, Leslie
    Zhai, Suodi
    CLINICAL THERAPEUTICS, 2018, 40 (04) : 660 - 662
  • [38] Indinavir: A rare urinary stone in HIV-1-infected patients - Occurrence and crystal properties
    Tessadri, R
    Griesser, UJ
    Prillinger, M
    Wurst, K
    EUROPEAN POWDER DIFFRACTION EPDIC 8, 2004, 443-4 : 407 - 410
  • [39] Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir
    Jann, Michael W.
    Spratlin, Vicky
    Momary, Kathryn
    Zhang, Hailing
    Turner, David
    Penzak, Scott R.
    Wright, Alan
    VanDenBerg, Chad
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (05) : 715 - 721
  • [40] No drug-drug interaction between cerivastatin and nifedipine
    Sachse, R
    Brendel, E
    Mück, W
    Rohde, G
    Ochmann, K
    Horstmann, R
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R174 - R174
12345